RHJA
NVRO

Rice Hall James & Associates’s NEVRO CORP. NVRO Stock Holding History

Rice Hall James & Associates’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-12,517
Closed -$1.47M – 289
2019
Q4 		$1.47M Sell
12,517
-10,913
-47% -$1.08M 0.05% 205
2019
Q3 		$2.01M Sell
23,430
-11,479
-33% -$869K 0.07% 166
2019
Q2 		$2.26M Buy
34,909
+1,774
+5% +$110K 0.08% 162
2019
Q1 		$2.07M Buy
33,135
+22,312
+206% +$1.05M 0.07% 184
2018
Q4 		$421K Buy
+10,823
New +$481K 0.02% 270

Other funds holding NVRO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Rice Hall James & Associates's NVRO Position: Q1 2020 in Review

Rice Hall James & Associates sold out of NEVRO CORP. (NVRO) in Q1 2020, closing a stake of 12,517 shares — an estimated $1.47M sold.

Rice Hall James & Associates first reported a position in NVRO in Q4 2018 and held it in 5 quarters. The position peaked at $2.26M in Q2 2019. 182 funds tracked by Wall St. Rank hold NVRO as of Q1 2020.

  • Rice Hall James & Associates reported no remaining NEVRO CORP. position as of Q1 2020 after selling out during the quarter.
  • Rice Hall James & Associates sold 12,517 NEVRO CORP. shares in Q1 2020, an estimated $1.47M.
  • Rice Hall James & Associates first reported a position in NEVRO CORP. in Q4 2018 and held it in 5 quarters.
  • Rice Hall James & Associates's NEVRO CORP. position peaked at $2.26M in Q2 2019.
  • 182 funds tracked by Wall St. Rank held NEVRO CORP. as of Q1 2020.

Based on Rice Hall James & Associates's 13F filing for Q1 2020, filed 15 May 2020.